Fovea-Involved Outer Retinal Abnormality Induced by a Novel RET Inhibitor

This case report describes an outer retinal abnormality associated with taking a RET inhibitor during a clinical trial in a 52-year-old patient with right lung adenocarcinoma and a RET gene fusion.

Authors

Institutions

Publication Details

Journal
JAMA Ophthalmology
Published
2024-12-12
DOI
https://doi.org/10.1001/jamaophthalmol.2024.5236
Primary Topic
Cancer-related Molecular Pathways
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Fovea-Involved Outer Retinal Abnormality Induced by a Novel RET Inhibitor

Jianqin Lei, Qianyan Kang, Shan Gao, Shimin Tan et al.
JAMA Ophthalmology
Cancer-related Molecular Pathways
article

Fovea-Involved Outer Retinal Abnormality Induced by a Novel RET Inhibitor

Jianqin Lei, Qianyan Kang, Shan Gao, Shimin Tan, Langxuan Yuan
article en

Abstract

This case report describes an outer retinal abnormality associated with taking a RET inhibitor during a clinical trial in a 52-year-old patient with right lung adenocarcinoma and a RET gene fusion.

JAMA OphthalmologyVol. 143(2)
First Affiliated Hospital of Xi'an Jiaotong University (CN)
Good health and well-being
Openalex Percentile: Top 60%
Cancer-related Molecular Pathways
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Fovea-Involved Outer Retinal Abnormality Induced by a Novel RET Inhibitor — Jianqin Lei, Qianyan Kang, et al. · JAMA Ophthalmology (2024) | TGRS Research Map | TGRS